ישראל - עברית - Ministry of Health

medison pharma ltd - dextromethorphan hydrobromide; quinidine sulfate - קפסולות - quinidine sulfate 10 mg; dextromethorphan hydrobromide 20 mg - quinidine - quinidine - for the treatment of pseudobulbar affect (pba) in als and ms patients only.

ישראל - עברית - Ministry of Health

medison pharma ltd - ivabradine as hydrochloride - טבליות מצופות פילם - ivabradine as hydrochloride 7.5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.

ישראל - עברית - Ministry of Health

medison pharma ltd - ivabradine as hydrochloride - טבליות מצופות פילם - ivabradine as hydrochloride 5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.

ישראל - עברית - Ministry of Health

medison pharma ltd - bezafibrate - טבליות עם שחרור מושהה - bezafibrate 400 mg - bezafibrate - bezafibrate - hyperlipidemia of types iia, iib, iii, iv, v in patients where diet alone is insufficient.

ישראל - עברית - Ministry of Health

medison pharma ltd - somatropin 5 mg / 1 ml - solution for injection - somatropin - 1. long-term treatment of children with growth failure due to inadequateendogenous growth hormone secretion.2. long-term treatment of growth failure associated with turner syndrome. 3. treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation. 4. replacement of endogenous growth hormone in adults with growth hormone deficiency or either childhood or adult-onset etiology. growth hormone deficiency of either childhood or adult-onset etiology. growth hormone deficiency should be confirmed appropriately prior to treatment.

ישראל - עברית - Ministry of Health

medison pharma ltd - lanreotide acetate - אבקה וממס להכנת תרחיף להזרקה - lanreotide acetate 0.03 g/vial - lanreotide - lanreotide - treatment of acromegaly (when the treatment of growth hormone is not normalized after surgery and/or radiotherapy). treatment of the clinical symptoms of carcinoid tumors (after a test injection). treatment of primary thyrotropic adenomas responsible for hypethyroidism as a preparation for / or as a complement to surgery and/or radiotherapy or where these therapies are unsuitable.

ישראל - עברית - Ministry of Health

medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 60 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.

ישראל - עברית - Ministry of Health

medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 90 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.

ישראל - עברית - Ministry of Health

medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 120 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.

ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as diaspartate - תמיסה להזרקה - pasireotide as diaspartate 0.3 mg/ml - pasireotide - pasireotide - treatment of adult patients with cushing’s disease for whom surgery is not an option or for whom surgery has failed.